5E Advanced Materials (NASDAQ:FEAM) Releases Earnings Results, Beats Expectations By $0.01 EPS

5E Advanced Materials (NASDAQ:FEAM) issued its earnings results on Tuesday. The company reported ($0.35) EPS for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.01, FiscalAI reports.

Here are the key takeaways from 5E Advanced Materials’ conference call:

• 5E signed its first offtake heads of agreement for 7,500 tons of boric acid per year, with optional volume up to 10,000 tons, marking a major step toward commercialization and project financing.
• The company said customer interest is growing after a March roadshow, and management expects the new agreement to be the first of additional offtakes that could help support debt underwriting.
• 5E reported successful development of metaboric acid, a higher-value product with about 80% B2O3 equivalent content, and said samples are being tested by customers while a provisional patent was filed.
• The company also launched a ferroboron trial program aimed at serving specialty steel and permanent magnet supply chains, with initial testing underway and customer samples expected in the coming weeks.
• 5E said its balance sheet was strengthened by a $36 million equity offering, and it is progressing with EXIM-related diligence and other financing work to support the next phase of the Fort Katy project.

5E Advanced Materials Price Performance

FEAM stock traded down $0.12 during mid-day trading on Tuesday, reaching $1.51. 323,199 shares of the company’s stock were exchanged, compared to its average volume of 303,617. The stock’s 50 day moving average is $1.64 and its 200 day moving average is $2.83. 5E Advanced Materials has a 12-month low of $1.17 and a 12-month high of $7.50. The company has a market cap of $35.50 million, a price-to-earnings ratio of -0.57 and a beta of 1.84.

Wall Street Analyst Weigh In

FEAM has been the topic of a number of recent research reports. HC Wainwright lowered their target price on 5E Advanced Materials from $9.25 to $5.75 and set a “buy” rating on the stock in a research note on Monday, March 9th. Wall Street Zen downgraded 5E Advanced Materials from a “sell” rating to a “strong sell” rating in a research note on Saturday, May 2nd. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of 5E Advanced Materials in a research report on Monday, April 20th. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, 5E Advanced Materials presently has a consensus rating of “Hold” and an average target price of $6.38.

Hedge Funds Weigh In On 5E Advanced Materials

A number of hedge funds have recently made changes to their positions in FEAM. Mercer Global Advisors Inc. ADV purchased a new position in 5E Advanced Materials during the fourth quarter worth approximately $674,000. XTX Topco Ltd acquired a new stake in shares of 5E Advanced Materials in the fourth quarter valued at approximately $124,000. &PARTNERS purchased a new position in shares of 5E Advanced Materials during the fourth quarter worth approximately $191,000. Marshall Wace LLP acquired a new position in shares of 5E Advanced Materials in the 4th quarter valued at $282,000. Finally, State Street Corp acquired a new stake in 5E Advanced Materials during the 4th quarter worth $37,000.

About 5E Advanced Materials

5E Advanced Materials, Inc develops and manufactures high-performance anode materials for lithium-ion batteries, specializing in silicon-carbon composite solutions. The company’s proprietary processes yield anode materials that deliver enhanced energy density, extended cycle life and faster charge rates compared to conventional graphite anodes. These advanced materials are targeted at electric vehicle manufacturers, consumer electronics producers and grid-scale energy storage providers seeking to improve battery performance and sustainability.

The firm operates a pilot production facility in Harrodsburg, Kentucky, where it carries out research, development and small-scale manufacturing to validate its processes and assess commercial viability.